# FDA Inspection 1060236 - Vitalant - June 29, 2018

Source: https://www.keypedia.com/records/fda_inspections/vitalant/487472f6-9d63-4dab-b262-cdfd23e997c5
Source feed: FDA_Inspections

> FDA Inspection 1060236 for Vitalant on June 29, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1060236
- Company Name: Vitalant
- Inspection Date: 2018-06-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1260496 - 2025-01-23](https://www.keypedia.com/records/fda_inspections/vitalant/2cd8ca70-8b75-4b4a-b06c-4006c13c401b)
- [FDA Inspection 1260496 - 2025-01-23](https://www.keypedia.com/records/fda_inspections/vitalant/52e865d3-3d08-4f07-bbfd-74b999cb4499)
- [FDA Inspection 1169573 - 2022-05-06](https://www.keypedia.com/records/fda_inspections/vitalant/8df65266-3ee8-4514-bdfe-7548582a9048)
- [FDA Inspection 1169573 - 2022-05-06](https://www.keypedia.com/records/fda_inspections/vitalant/cef44bda-2f7f-493a-9081-0204047f8627)
- [FDA Inspection 989063 - 2016-08-25](https://www.keypedia.com/records/fda_inspections/vitalant/0136808a-01ec-4224-8467-feb216658378)

Company: https://www.keypedia.com/companies/vitalant/19fe12d3-15ee-43cf-a9de-38d1d5dac248

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d